Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Predictions

buy
Eli Lilly Corp.

Start price
Target price
Perf. (%)
€397.00
24.05.23
€464.75
24.05.24
88.34%
25.05.24

buy
Eli Lilly Corp.

Start price
Target price
Perf. (%)
€397.00
24.05.23
€462.89
24.05.24
88.34%
25.05.24

buy
Novavax Inc.

Start price
Target price
Perf. (%)
€12.15
13.05.24
-
13.05.25
16.83%
25.05.24

Top 10 in its market
Could be worthwhile Investment >10% per year
Leading role in innovation
Very Future proof/growth oriented business model
buy
Adaptimmune Therapeutics PLC ADR

Start price
Target price
Perf. (%)
€1.14
15.05.24
-
15.05.25
-16.67%
24.05.24

Risky Investment
buy
QIAGEN NV

Start price
Target price
Perf. (%)
€42.94
23.05.23
-
23.05.24
-2.77%
24.05.24

buy
Chimerix Inc.

Start price
Target price
Perf. (%)
€1.44
22.05.23
-
22.05.24
-39.35%
23.05.24

buy
Horizon Pharma plc

Start price
Target price
Perf. (%)
€92.10
21.05.23
-
21.05.24
19.87%
22.05.24

Moleculin Biotech Inc

Start price
Target price
Perf. (%)
€0.60
21.05.23
-
21.05.24
-27.73%
22.05.24

Ampio Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€0.060
20.05.23
-
20.05.24
-
21.05.24

Arca Biopharma

Start price
Target price
Perf. (%)
€1.85
20.05.23
-
20.05.24
58.92%
21.05.24

Advaxis Inc.

Start price
Target price
Perf. (%)
€0.059
20.05.23
-
20.05.24
-
21.05.24

Minerva Neurosciences Inc.

Start price
Target price
Perf. (%)
€6.05
20.05.23
-
20.05.24
-63.97%
21.05.24

buy
Catalent Inc.

Start price
Target price
Perf. (%)
€33.15
19.05.23
€40.00
19.05.24
54.24%
20.05.24

Could be worthwhile Investment >10% per year
buy
Minerva Neurosciences Inc.

Start price
Target price
Perf. (%)
€5.88
19.05.23
€3.00
19.05.24
-61.56%
20.05.24

Standard Investments for future growth
Higher EBIT margin than peer group
Very low/no dividend yield expected
ROE lower than 10% per year
buy
Novavax Inc.

Start price
Target price
Perf. (%)
€8.70
11.05.24
€82.00
11.05.25
39.26%
19.05.24

Could be very worthwhile Investment >20% year
Revenue growth > 30% per year expected
Rising EBIT margin expected
Low dividend yield expected
buy
AnaptysBio Inc

Start price
Target price
Perf. (%)
€17.30
18.05.23
-
18.05.24
31.79%
19.05.24

buy
Pfizer Inc.

Start price
Target price
Perf. (%)
€34.10
18.05.23
-
18.05.24
-22.43%
19.05.24

buy
Teva Pharmaceutical Industries Ltd ADR

Start price
Target price
Perf. (%)
€7.74
18.05.23
-
18.05.24
95.09%
19.05.24

buy
Gilead Sciences Inc

Start price
Target price
Perf. (%)
€73.00
16.05.23
€91.88
16.05.24
-14.51%
17.05.24

AEterna Zentaris Inc.

Start price
Target price
Perf. (%)
€2.63
14.05.23
-
14.05.24
-28.90%
15.05.24

buy
Eli Lilly Corp.

Start price
Target price
Perf. (%)
€403.60
14.05.23
€700.00
14.05.24
76.01%
15.05.24

Could be worthwhile Investment >10% per year
Insmed Inc.

Start price
Target price
Perf. (%)
€23.60
13.05.24
€15.00
13.05.25
0.00%
14.05.24

Could be very worthwhile Investment >20% year
buy
AC Immune Ltd

Start price
Target price
Perf. (%)
€3.33
13.05.24
-
13.05.25
-7.07%
14.05.24

Could be worthwhile Investment >10% per year
Good culture
Capable Management
Little innovation
buy
Sanofi S.A. ADR

Start price
Target price
Perf. (%)
€50.00
13.05.23
-
13.05.24
-9.60%
14.05.24

Adverum Biotechnologies Inc.

Start price
Target price
Perf. (%)
€0.73
13.05.23
-
13.05.24
102.74%
14.05.24